Cat Oyler, vice president, global public health, tuberculosis at Johnson & Johnson, explains that by shifting focus to prevention, we can help to both reduce pressure on an increasingly
pharmaphorum caught up with Erik Nordkamp, outgoing president of the Association of the British Pharmaceutical Industry (ABPI), who has also changed role at Pfizer to become the organisatio
England’s NHS is gearing up towards the ‘go live’ of a new digital transformation team that aims to drive service improvement using health data and technology.
The Topol Review of the training needs of the future NHS workforce has published its recommendations – including an increase in the number of clinicians trained to use digital, AI and robot
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
